vs
GLOBUS MEDICAL INC(GMED)与Medline Inc.(MDLN)财务数据对比。点击上方公司名可切换其他公司
Globus Medical是总部位于美国宾夕法尼亚州奥杜邦的上市骨科医疗器械企业,专注于相关产品的设计、研发与商业化,助力外科医生为肌肉骨骼系统疾病患者提供治疗方案,促进患者康复。
Medline Inc.是总部位于美国伊利诺伊州诺斯菲尔德的医疗企业,为美国规模最大的私营医疗用品制造商及分销商,可面向全护理场景提供产品、培训、临床项目及相关服务。2021年6月,公司被黑石、凯雷、赫尔曼&弗里德曼组成的私募财团以340亿美元估值收购,是史上规模最大的杠杆收购案之一。
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GMED
MDLN
| Q4 25 | $826.4M | — | ||
| Q3 25 | $769.0M | — | ||
| Q2 25 | $745.3M | — | ||
| Q1 25 | $598.1M | — | ||
| Q4 24 | $657.3M | — | ||
| Q3 24 | $625.7M | — | ||
| Q2 24 | $629.7M | — | ||
| Q1 24 | $606.7M | — |
净利润
GMED
MDLN
| Q4 25 | $140.6M | — | ||
| Q3 25 | $119.0M | — | ||
| Q2 25 | $202.8M | — | ||
| Q1 25 | $75.5M | — | ||
| Q4 24 | $26.5M | — | ||
| Q3 24 | $51.8M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $-7.1M | — |
毛利率
GMED
MDLN
| Q4 25 | 68.4% | — | ||
| Q3 25 | 67.2% | — | ||
| Q2 25 | 66.6% | — | ||
| Q1 25 | 67.3% | — | ||
| Q4 24 | 59.9% | — | ||
| Q3 24 | 56.8% | — | ||
| Q2 24 | 58.7% | — | ||
| Q1 24 | 60.2% | — |
营业利润率
GMED
MDLN
| Q4 25 | 20.5% | — | ||
| Q3 25 | 17.9% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 16.2% | — | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 1.3% | — |
净利率
GMED
MDLN
| Q4 25 | 17.0% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 27.2% | — | ||
| Q1 25 | 12.6% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 8.3% | — | ||
| Q2 24 | 5.0% | — | ||
| Q1 24 | -1.2% | — |
每股收益(稀释后)
GMED
MDLN
| Q4 25 | $1.01 | — | ||
| Q3 25 | $0.88 | — | ||
| Q2 25 | $1.49 | — | ||
| Q1 25 | $0.54 | — | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $0.38 | — | ||
| Q2 24 | $0.23 | — | ||
| Q1 24 | $-0.05 | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图